Robert W. Baird Initiates Coverage on Concentrix (NASDAQ:CNXC)

Robert W. Baird assumed coverage on shares of Concentrix (NASDAQ:CNXCFree Report) in a report issued on Thursday morning, MarketBeat reports. The firm issued an outperform rating and a $70.00 price target on the stock.

Other research analysts have also issued research reports about the stock. Bank of America dropped their price target on shares of Concentrix from $85.00 to $70.00 and set a neutral rating for the company in a research report on Thursday, September 26th. Canaccord Genuity Group dropped their target price on Concentrix from $125.00 to $100.00 and set a buy rating for the company in a report on Thursday, September 26th. Finally, Barrington Research decreased their price target on Concentrix from $84.00 to $70.00 and set an outperform rating on the stock in a research note on Thursday, September 26th. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of Buy and a consensus price target of $79.00.

Get Our Latest Report on CNXC

Concentrix Stock Performance

NASDAQ:CNXC opened at $52.58 on Thursday. Concentrix has a 52-week low of $50.23 and a 52-week high of $106.10. The company has a market cap of $3.42 billion, a price-to-earnings ratio of 12.17, a PEG ratio of 0.71 and a beta of 0.58. The firm’s 50-day moving average is $65.82 and its 200-day moving average is $63.22. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.56 and a current ratio of 1.57.

Concentrix (NASDAQ:CNXCGet Free Report) last issued its earnings results on Wednesday, September 25th. The company reported $2.87 EPS for the quarter, missing the consensus estimate of $2.93 by ($0.06). The firm had revenue of $2.39 billion during the quarter, compared to the consensus estimate of $2.38 billion. Concentrix had a return on equity of 16.57% and a net margin of 2.18%. The firm’s revenue for the quarter was up 46.2% compared to the same quarter last year. During the same period last year, the business earned $2.54 earnings per share. Equities research analysts anticipate that Concentrix will post 10.18 earnings per share for the current year.

Concentrix Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 5th. Investors of record on Friday, October 25th will be issued a dividend of $0.333 per share. This represents a $1.33 dividend on an annualized basis and a yield of 2.53%. This is a boost from Concentrix’s previous quarterly dividend of $0.30. The ex-dividend date is Friday, October 25th. Concentrix’s dividend payout ratio (DPR) is currently 28.01%.

Insider Buying and Selling at Concentrix

In other Concentrix news, CEO Christopher A. Caldwell sold 9,823 shares of the stock in a transaction dated Friday, October 4th. The shares were sold at an average price of $52.70, for a total transaction of $517,672.10. Following the sale, the chief executive officer now owns 241,841 shares of the company’s stock, valued at $12,745,020.70. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CEO Christopher A. Caldwell sold 9,823 shares of the business’s stock in a transaction that occurred on Friday, October 4th. The shares were sold at an average price of $52.70, for a total value of $517,672.10. Following the completion of the transaction, the chief executive officer now owns 241,841 shares in the company, valued at $12,745,020.70. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Cormac J. Twomey sold 400 shares of the company’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $67.23, for a total value of $26,892.00. Following the transaction, the executive vice president now directly owns 29,727 shares in the company, valued at approximately $1,998,546.21. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 12,167 shares of company stock worth $653,747. 3.00% of the stock is currently owned by insiders.

Institutional Trading of Concentrix

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. SG Americas Securities LLC acquired a new position in Concentrix during the 2nd quarter valued at about $1,445,000. Vanguard Group Inc. lifted its holdings in Concentrix by 23.9% in the fourth quarter. Vanguard Group Inc. now owns 5,363,893 shares of the company’s stock valued at $526,788,000 after buying an additional 1,034,546 shares during the period. Natixis bought a new position in Concentrix in the first quarter valued at approximately $542,000. Tweedy Browne Co LLC boosted its stake in Concentrix by 21.6% in the first quarter. Tweedy Browne Co LLC now owns 173,338 shares of the company’s stock valued at $11,478,000 after acquiring an additional 30,798 shares during the last quarter. Finally, Groupe Bruxelles Lambert acquired a new stake in Concentrix during the 4th quarter worth $861,662,000. 90.34% of the stock is currently owned by institutional investors and hedge funds.

Concentrix Company Profile

(Get Free Report)

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

See Also

Analyst Recommendations for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.